|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/40 | (2006.01) |
| C07D 207/09 | (2013.01) | ||
| A61K 31/166 | (2006.01) | ||
| A61P 25/18 | (2018.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/166 | (2013.01) | ||
| A61P 25/18 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61P 25/24 | (2006.01) | ||
| A61K 31/40 | (2013.01) | ||
| C07D 207/09 | (2006.01) |
| (11) | Number of the document | 3544606 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17873556.9 |
| Date of filing the European patent application | 2017-11-28 | |
| (97) | Date of publication of the European application | 2019-10-02 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/063529 |
| Date | 2017-11-28 |
| (87) | Number | WO 2018/098497 |
| Date | 2018-05-31 |
| (30) | Number | Date | Country code |
| 201662427062 P | 2016-11-28 | US | |
| 201762508263 P | 2017-05-18 | US |
| (72) |
VAINO, Andrew R. , US
GRATTAN, Vincent T. , US
PRENSKY, Zachary , US
|
| (73) |
LB Pharmaceuticals Inc. ,
575 Madison Avenue
Floor 10, New York, New York 10022,
US
|
| (54) | PSYCHOTROPIC AGENTS AND USES THEREOF |
| PSYCHOTROPIC AGENTS AND USES THEREOF |